Submit a comment

CAR T cells targeting the glycoprotein GD2 show potent antitumor efficacy in high-risk ependymoma models

Antonio Carlos Tallon-Cobos, Konstantinos Vazaios, Piotr Waranecki, Marliek van Hoesel, Annelisa Cornel, Benjamin Schwalm, Norman Mack, Ella de Boed, Jasper van der Lugt, Stefan Nierkens, Marcel Kool, Eelco W. Hoving, Dennis S. Metselaar, Esther Hulleman

Antonio Carlos Tallon-Cobos, Konstantinos Vazaios, Piotr Waranecki, Marliek van Hoesel, Annelisa Cornel, Benjamin Schwalm, Norman Mack, Ella de Boed, Jasper van der Lugt, Stefan Nierkens, Marcel Kool, Eelco W. Hoving, Dennis S. Metselaar, Esther Hulleman

View: Text | PDF

Research Letter Immunology Neuroscience Oncology

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

• Comments appear on the Journal’s website and are linked from the original article’s web page.
• Authors are notified by email if their comments are posted.
• The Journal reserves the right to edit comments for length and clarity.
• No appeals will be considered.
• Comments are not indexed in PubMed.

Specific requirements

• Maximum length, 400 words
• Entered as plain text or HTML
• Author’s name and email address, to be posted with the comment
• Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
• Comments may not include figures